Literature DB >> 9187505

Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest.

P Mair1, J Mair, J Bleier, C Hörmann, D Balogh, B Puschendorf.   

Abstract

The aim of the study was to investigate the release of natriuretic peptides during myocardial ischaemia and reperfusion associated with cardioplegic cardiac arrest. Brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) concentrations were measured in paired arterial, central venous and coronary sinus blood samples in 19 patients undergoing elective coronary artery bypass grafting before aortic crossclamping and 1, 5, 10 and 20 min after aortic declamping. Peak myocardial BNP release after aortic declamping was significantly higher than baseline values before aortic crossclamping. Both peak and cumulative BNP release during reperfusion correlated significantly with the severity of ischaemia, as assessed by myocardial lactate production. In 3 patients with perioperative myocardial ischaemia, cumulative and peak myocardial BNP release after aortic unclamping was markedly higher than in the remaining 16 uneventful patients. Myocardial ANP release during reperfusion was not significantly different from baseline values before aortic crossclamping. In conclusion, our data demonstrate a significantly enhanced myocardial BNP release early during reperfusion of the human heart after global ischaemia associated with cardioplegic cardiac arrest.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187505     DOI: 10.1016/s0009-8981(97)06518-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.

Authors:  Osman Saribulbul; Ilker Alat; Senol Coskun; Anil Z Apaydin; Tahir Yagdi; Mefkure Kiliccioglu; Emin Alp Alayunt
Journal:  Tex Heart Inst J       Date:  2003

2.  Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction.

Authors:  Charles A Nelson; Colin Case; Jane McCrohon; Thomas H Marwick
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

3.  Changes in N-terminal pro B-type natriuretic peptide concentration: comparative study of percutaneous transluminal coronary angioplasty and off-pump coronary artery bypass graft.

Authors:  Hyun Koo Kim; Hark Jei Kim; Jin Won Kim; Young-sang Sohn; Young Ho Choi
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

4.  Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.

Authors:  Fatih Islamoglu; Kaan Ozcan; Anil Z Apaydin; Cahide Soydas; Oya Bayindir; Isa Durmaz
Journal:  Tex Heart Inst J       Date:  2008

5.  Changes of ghrelin and brain natriuretic peptide levels in systemic vascular resistance after cardiopulmonary bypass.

Authors:  A Rahman; S Aydin; M K Bayar; I Sahin
Journal:  J Physiol Biochem       Date:  2008-09       Impact factor: 4.158

6.  B-type natriuretic peptide as a surrogate marker for survival in patients undergoing cardiac surgery.

Authors:  Ju Yong Lim; Sung Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee; Joon Bum Kim
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.